黑料官网

header-logo
GettyImages-758308167-hero
Biostatistics
Brent R. Logan, PhD

Brent R. Logan, PhD

Director & Professor, Biostatistics

Locations

  • Biostatistics

Contact Information

Education

PhD, Northwestern University, Evanston, IL, 2001
MS, Northwestern University, Evanston, IL, 1998
BS, Vanderbilt University, Nashville, TN, 1996

Research Experience

  • Multiple Comparison Procedures

Research Interests

Dr. Brent Logan joined biostatistics in the summer of 2001. He has methodological research interests in multiple comparison procedures, clinical trial design, and survival analysis. Research in multiple testing includes methods for analyzing multiple endpoints in clinical trials, analysis of dose-response studies, and multiplicity adjustment in functional MRI studies. His interests in clinical trial design include randomized phase 2 clinical trials and biologic assignment trials in bone marrow transplant studies. Recent work in survival analysis has focused on inference for competing risks and multistate models using pseudo-value regression, analysis in the presence of crossing survival curves, and methods for the analysis of complex bone marrow transplant data. He is a biostatistician for the and the , as well as a statistical consultant for the .

Publications

  • (Rayes A, Logan BR, Liu X, Dara J, Buckley RH, Oved JH, Kapoor N, Kapadia M, Chandra S, Martinez CA, Bunin N, Chandrakasan S, Chen K, Bednarski JJ, Haines HL, Eissa H, Talano JM, Keller MD, Ebens CL, Chaudhury S, Shereck EB, Aquino VM, Knutsen AP, Alexander JL, Gillio AP, Chellapandian D, Shah AJ, Miller HK, Vander Lugt MT, Seroogy CM, Dorsey MJ, Mousallem T, Parrott RE, O'Reilly RJ, Aguayo-Hiraldo PI, Prockop SE, Dávila Saldaña BJ, Thakar MS, Burroughs LM, Torgerson TR, Leiding JW, Marsh RA, Griffith LM, Pulsipher MA, Kohn DB, Notarangelo LD, Cowan MJ, Puck JM, Cuvelier GDE, Heimall J, Haddad E, Pai SY, Dvorak CC.) Blood Adv. 2025 Nov 25 PMID: 41289158 11/25/2025

  • (Artz AS, Logan BR, Saber W, Geller N, Bellach A, Kou J, Wood WA, McCarty J, Knight TG, Runaas L, Johnston L, Walston JD, Nakamura R, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris LE Jr, Imus P, Hogan WJ, Nadiminti KV, Bhatt VR, Olin RL, Maakaron JE, Sobecks RM, Wall SA, Mattila D, Protz B, Devine SM, Horowitz MM, Sorror ML.) Blood Adv. 2025 Nov 21 PMID: 41269781 11/21/2025

  • (Levis MJ, Hamadani M, Logan BR, Jones RJ, Singh AK, Litzow MR, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Oshima MU, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly LS, Kim HJ, Stelljes M, Najima Y, Onozawa M, Thomson K, Chen C, Hasabou N, Rosales M, Hill JE, Gill SC, Nuthethi R, King D, Mendizabal A, Devine SM, Horowitz MM, Chen YB.) Blood Adv. 2025 Oct 28;9(20):5123-5133 PMID: 40590852 PMCID: PMC12550156 07/01/2025

  • (Strouse C, Juckett M, Logan BR, Estrada-Merly N, Peterson A, Preussler JM, Truong TH, Troy JD, Khera N, Wood WA, Rangarajan HG, Akard LP, Bhatt NS, Sharma A, Rizzo JD, Saber W.) JCO Oncol Pract. 2025 Oct 02:OP2500115 PMID: 41037768 PMCID: PMC12494149 SCOPUS ID: 2-s2.0-105026897637 10/02/2025

  • (Fang X, Kim S, Martens MJ, Logan BR, Woo Ahn K.) Stat Med. 2025 Aug;44(18-19):e70233 PMID: 40817818 PMCID: PMC12614236 SCOPUS ID: 2-s2.0-105013464110 08/16/2025

  • (Sorror ML, Saber W, Logan B, Geller N, Bellach A, Kou J, Wood W, McCarty JM, Knight TG, Runaas L, Johnston L, Walston J, Nakamura R, Jarrett L, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris LE, Imus PH, Hogan WJ, Nadiminti K, Bhatt VR, Olin R, Maakaron J, Sobecks R, Wall SA, Mattila D, Protz B, Devine SM, Horowitz MM, Artz AS.) Blood Adv. 2025 Jul 08;9(13):3268-3280 PMID: 40101246 PMCID: PMC12246602 SCOPUS ID: 2-s2.0-105009768260 03/18/2025

  • (Martens MJ, Lian Q, Geller NL, Leifer ES, Logan BR.) Clin Trials. 2025 Jun;22(3):267-278 PMID: 40396502 PMCID: PMC12096354 SCOPUS ID: 2-s2.0-85213536554 05/21/2025

  • (Levis MJ, Hamadani M, Logan BR, Jones RJ, Singh AK, Litzow MR, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Oshima MU, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly LS, Kim HJ, Stelljes M, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Chen C, Hasabou N, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Mendizabal A, Devine SM, Horowitz MM, Chen YB.) Blood. 2025 May 08;145(19):2138-2148 PMID: 39775763 PMCID: PMC12105721 01/08/2025

  • (Kassim AA, Walters MC, Eapen M, Smith M, Logan BR, Solh M, McKinney C, Nieder M, Ross M, Kent M, Abusin GA, Mallhi K, Silva JG, Shaughnessy P, Kanter J, Haines H, Farah R, Khaled YA, Ritzau N, Mendizabal A, Abraham A, Bollard C, Cooke K, de la Fuente J, Hanna R, Horowitz MM, Jordan LC, Bakshi N, Krishnamurti L, Leifer E, Mahadeo KM, Shenoy S, Jones RJ, DeBaun MR, Brodsky RA.) NEJM Evid. 2025 Mar;4(3):EVIDoa2400192 PMID: 39998298 PMCID: PMC11932095 02/25/2025

  • (Martens MJ, Lian Q, Geller NL, Leifer ES, Logan BR.) Clinical Trials. June 2025;22(3):267-278 SCOPUS ID: 2-s2.0-85213536554 06/01/2025

  • (Khanal M, Logan BR, Banerjee A, Fang X, Ahn KW.) Pharm Stat. 2025;24(1):e2464 PMID: 39846144 PMCID: PMC12147052 SCOPUS ID: 2-s2.0-85216016393 01/23/2025

  • (Spellman SR, Sparapani R, Maiers M, Shaw BE, Laud P, Bupp C, He M, Devine SM, Logan BR.) Blood Adv. 2024 Dec 10;8(23):6082-6087 PMID: 39368807 PMCID: PMC11652765 SCOPUS ID: 2-s2.0-85212173730 10/06/2024

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.